Rafferty Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $328K | Sell |
|
|||||
|
2024
Q4 | $353K | Sell |
|
|||||
|
2024
Q3 | $426K | Sell |
|
|||||
|
2024
Q2 | $408K | Sell |
|
|||||
|
2024
Q1 | $520K | Buy |
|
|||||
|
2023
Q4 | $486K | Buy |
|
|||||
|
2023
Q3 | $326K | Buy |
|
|||||
|
2023
Q2 | $307K | Buy |
|
|||||
|
2023
Q1 | $234K | Sell |
|
|||||
|
2022
Q4 | $236K | Sell |
|
|||||
|
2022
Q3 | $220K | Buy |
|
|||||
|
2022
Q2 | $255K | Sell |
|
|||||
|
2022
Q1 | $456K | Sell |
|
|||||
|
2021
Q4 | $464K | Sell |
|
|||||
|
2021
Q3 | $356K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $371K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $222K | Sell |
|
|||||
|
2019
Q3 | $94K | Buy |
|